About Concord Hospital's Haematology Clinical Research Unit

The Clinical Research Unit at Concord Repatriation General Hospital’s Department of Haematology was established in 2005. It is part of Concord Cancer Centre and is now one of the largest, most rapidly growing, Clinical Trials Units in Australia – and the largest clinical research unit for blood cancers in NSW.

The team

Our team, led by the Director of the Clinical Research Unit, Dr Nicole Wong Doo and the Acting Manager Clinical Research Unit, Ms Jennifer Harman, includes nine haematologists, two research fellows, thirteen data managers, and six research nurses, along with the entire department’s laboratory, nursing, pharmacy and clerical staff behind us.

Our clinical trials

We conduct world-leading, patient-centered clinical trials to access and develop innovative therapies to treat patients with Leukaemia, Lymphoma, Myeloma and other blood disorders – cutting-edge research which evaluates the safety and benefits of new medicines.

For more information about the Haematology Research Department’s achievements for 2022 please view the annual report here:
Haematology Research | Sydney Local Health District (nsw.gov.au)

Myhodgkin Myhealth App Launched

Dr Nicole Wong Doo and Professor Judith Trotman, haematologists at Concord Hospital who are passionate about improving the quality of life for lymphoma patients, have announced the launch of the Myhodgkin Myhealth app.

Through Myhodgkin Myhealth, they aim to understand the health of Hodgkin lymphoma patients from their own perspective and use this data to shape and improve Hodgkin therapy.

Myhodgkin Myhealth is an Australian-led research project designed to allow patients to self-enter their own vital data on their Hodgkin lymphoma treatment and the medical issues they face following therapy, including fertility challenges, nerve damage and heart and lung issues. This information will contribute to the development and implementation of future therapies for Hodgkin Lymphoma, ensuring the patients’ experiences are heard and listened to.

The Myhodgkin Myhealth research project has been designed as a mobile app, available at Apple and Google Play stores to allow Hodgkin survivors to participate whether at the hospital or clinic or at home.

Myhodgkin Myhealth is an investigator-initiated research project, supported through funding from the Foundation for a Bloody Great Cause’
For more information and details of the App please visit
https://myhodgkinmyhealth.com

Benefits for patients

Clinical trials improve outcomes for patients and have greatly increased the cure rates for many blood cancers over recent years.

By participating in these world-leading clinical trials, more than 1000 patients at Concord Hospital have benefited greatly from millions of dollars’ worth of new and innovative treatments, long before they are publicly funded.

For these patients and their families, participation in this clinical research offers them greater hope for a cure and a better quality of life.

Our financial independence

It is the Haematology Clinical Research Unit's reputation for quality and independence that has made us an international research leader and ensures we truly deliver world-class care, locally.

To support our important focus on research that meets our local community's needs, we rely heavily on local fundraising. This fundraising ensures our financial viability and guarantees our independence.

That's why our community fundraising and your support are so important - there are many more patients who need your help.